|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01548066 |
|
Date of registration:
|
20/07/2011 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss
|
|
Scientific title:
|
The Efficacy and Safety of Topical Valproic Acid in Preventing Hair Loss |
|
Date of first enrolment:
|
September 2011 |
|
Target sample size:
|
40 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01548066 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
Korea, Republic of
| | | | | | | |
|
Contacts
|
|
Name:
|
Oh Sang Kwon, Prof. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Seoul National Univeristy Hospital |
|
|
Name:
|
Seong Jin Jo, Fellow |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Seoul National University Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- age: 19 years ~ 45 years
- subjects with AGA (Hamilton&Norwood grad III~IV)
- subjects who are able to be followed for next 24 weeks.
Exclusion Criteria:
- subjects with severe medical problems including cardiovascular diseases, renal
problems, and chronic metabolic disease
- subjects with AGA treated with surgical methods (hair TPL)
- subjects who has ever applied minoxidil in recent 3 months or has taken finasteride
or dutasteride in recent 6 months.
- subjects who took medicine which can affect the hair growth
- subjects with alopecia other than AGA
Age minimum:
19 Years
Age maximum:
45 Years
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Androgenetic Alopecia
|
|
Male Pattern Baldness
|
|
Intervention(s)
|
|
Drug: Control placebo
|
|
Drug: Valproic Acid
|
|
Primary Outcome(s)
|
|
linear hair growth rate
[Time Frame: 24th week]
|
|
Secondary Outcome(s)
|
|
final hair density
[Time Frame: 24th week]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|